466
Views
62
CrossRef citations to date
0
Altmetric
Research Article

Self-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug

, , , , &
Pages 264-276 | Received 04 Sep 2009, Accepted 22 Oct 2009, Published online: 26 Nov 2009

References

  • Bulpitt P, Aeschlimann D. (1999). New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res, 47: 152–169.
  • Cavallaro G, Giammona G, Lombardo R, Sciascia L, Turco Liveri ML. (2006). Amphiphilic derivatives of a polyaspartamide: their aggregation and solubilization ability. Tensiometric and spectrophotometric studies. Colloids Surf A: Physicochem Eng Aspects, 289: 10–16.
  • Craparo EF, Cavallaro G, Bondì ML, Mandracchia, D, Giammona G. (2006). Preparation, physico-chemical characterization, and intracellular uptake. Biomacromolecules, 7: 3083–3092.
  • Creuzet C, Kadi S, Rinaudo M, Auzély-Velty R. (2006). New associative systems based on alkylated hyaluronic acid. Synthesis and aqueous solution properties. Polymer, 47: 2706–2713.
  • Meo CD, Panza L, Capitani D, Mannina L, Banzato A, Rondina M, Renier D, Rosato A, Crescenzi V. (2007). Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy. Biomacromolecules, 8: 552–559.
  • Entwistle J, Hall CL, Turley EA. (1996). HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem, 61: 569–577.
  • Fraser JR, Laurent TC, Laurent UB. (1997). Hyaluronan: its nature, distribution, functions and turnover. J Intern Med, 242: 27–33.
  • Gref R, Couvreur P, Barratt G, Mysiakine E. (2003). Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials, 24: 4529–4537.
  • Hall CL, Yang B, Yang X, Zhang S, Turley M, Samuel S, Lange LA, Wang C, Curpen GD, Savani RC, Greenberg AH, Turley EA. (1995). Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell, 82: 19–26.
  • Herrlich P, Sleeman J, Wainwright D, König H, Sherman L, Hilberg F, Ponta H. (1998). How tumor cells make use of CD44. Cell Adhes Commun, 6: 141–147.
  • Hu FQ, Meng P, Dai YQ, Du YZ, You J, Wei XH, Yuan H. (2008). PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur J Pharm Biopharm, 70: 749–757.
  • Hua Q, Knudson CB, Knudson W. (1993). Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci, 106: 365–375.
  • Hyung W, Ko H, Park J, Lim E, Park SB, Park YJ, Yoon HG, Suh JS, Haam S, Huh YM. (2008). Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment. Biotechnol Bioeng, 99: 442–454.
  • Kim D, Lee ES, Park K, Kwon IC, Bae YH. (2008). Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. Pharm Res, 25: 2074–2082.
  • Knudson CB, Knudson W. (1993). Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J, 7: 1233–1241.
  • Knudson CB, Knudson W. (2001). Cartilage proteoglycans. Semin Cell Dev Biol, 12: 69–78.
  • Laurent TC. (1987). Biochemistry of hyaluronan. Acta Otolaryngol Suppl, 442: 7–24.
  • Lee H, Lee K, Park TG. (2008). Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem, 19: 1319–1325.
  • Lee H, Mok H, Lee S, Oh YK, Park TG. (2007). Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release, 119: 245–252.
  • Liu SQ, Wiradharma N, Gao SJ, Tong YW, Yang YY. (2007). Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials, 28: 1423–1433.
  • Liu SQ, Tong YW, Yang YY. (2005). Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions. Biomaterials, 26: 5064–5074.
  • Luo Y, Bernshaw NJ, Lu ZR, Kopecek J, Prestwich GD. (2002). Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharm Res, 19: 396–402.
  • Luo Y, Prestwich GD. (1999). Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem, 10: 755–763.
  • Otsuka H, Nagasaki Y, Kataoka K. (2003). PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev, 55: 403–419.
  • Palumbo FS, Pitarresi G, Mandracchia D, Tripodo G, Giammona G. (2006). New graft copolymers of hyaluronic acid and polylactic acid: synthesis and characterization. Carbohyd Polym, 66: 379–385.
  • Peterson RM, Yu Q, Stamenkovic I, Toole BP. (2000). Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. Am J Pathol, 156: 2159–2167.
  • Pitarresi G, Craparo EF, Palumbo FS, Carlisi B, Giammona G. (2007). Composite nanoparticles based on hyaluronic acid chemically crosslinked with α,β-polyaspartylhydrazide Biomacromolecules, 8: 1890–1898.
  • Pouyani T, Prestwich GD. (1994). Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. Bioconjug Chem, 5: 339–347.
  • Shu XZ, Liu Y, Luo Y, Roberts MC, Prestwich GD. (2002). Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules, 3: 1304–1311.
  • Turley EA. 1989. The Biology of Hyaluronan. CIBA Foundation, Ed. J.Wiley & Sons, Ltd, Chichester, UK, pp. 121.
  • Xiangyang X, Ling L, Jianping Z, Shiyue L, Jie Y, Xiaojin Y, Jinsheng R. (2007). Preparation and characterization of N-succinyl-N′-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity. Colloids Surf B Biointerfaces, 55: 222–228.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.